학술논문

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Document Type
Article
Source
In Annals of Oncology January 2021 32(1):49-57
Subject
Breast tumors
Language
ISSN
0923-7534